Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The RETIRE Trial
NCT06552169Phase 2Recruiting
- Sponsor
- Singulera Therapeutics
- Start
- Jun 2025
- Primary completion
- Dec 2027
- Modality
- Cell Therapies
- Countries
- 2
01
Overview
A Phase 2 trial of TRK-001 in kidney transplant rejection, sponsored by Singulera Therapeutics. Started Jun 2025; status: recruiting.
02
Drugs
TRK-001
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT06552169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06552169.